Strategic Investment & M&A Integration
Case 1: Successful Cross-Border M&A Integration in Pharmaceutical Sector
Client: A leading pharmaceutical group
Challenge: Cultural conflicts and significant loss of key R&D team members following acquisition of a European innovative biopharma company
Solution: Provided full-cycle M&A integration services
Developed a "Sino-European integration" roadmap
Designed long-term incentives and project co-investment mechanisms for R&D personnel
Established cross-cultural communication and decision-making frameworks
Result: Achieved 92% retention of core team, advanced 2 innovative drugs to clinical Phase III within 18 months, with synergy value exceeding 30% of the acquisition price
Case 2: Industrial M&A in Smart Manufacturing
Client: A leading industrial automation company
Challenge: Post-merger business synergy below expectations, chaotic integration process
Solution:
Developed a detailed 100-day integration plan
Designed performance evaluation system based on synergy value creation
Established joint technology innovation teams
Result: Achieved R&D synergy within 6 months, reduced new product development cycle by 40%, and delivered 125% of first-year post-merger performance commitments